Clinical Trials Directory

Trials / Sponsors / Translational Research in Oncology

Translational Research in Oncology

Academic / Other · 10 registered clinical trials.

StatusTrialPhaseStarted
TerminatedRegorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
Carcinoma, Hepatocellular
Phase 32023-10-11
WithdrawnRegorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cance
Anal Squamous Cell Carcinoma, Colorectal Neoplasms, Soft Tissue Sarcoma
Phase 22023-04-30
CompletedSafety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced
Breast Cancer
Phase 12020-08-25
CompletedA Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide
Breast Cancer Female
EARLY_Phase 12017-09-05
TerminatedStudy of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
Epithelial Ovarian Cancer
Phase 22016-12-20
TerminatedClinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozo
Breast Neoplasms
Phase 22014-07-01
TerminatedStudy of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog
Breast Cancer
Phase 22009-02-01
CompletedStudy of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer
Breast Cancer
Phase 22009-02-01
TerminatedStudy of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Canc
Ovarian Neoplasms
Phase 22009-01-01
CompletedStudy of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer
Ovarian Neoplasms
Phase 22009-01-01